Lactalis Ingredients banner promoting an on-demand webinar about maintaining soft textures in high-protein bars.
Home
Vitamin C May Decrease COPD...

Vitamin C May Decrease COPD and Pneumonia Prognosis Inflammatory Diseases

30 Oct 2006
Image

It is suggested that the elevation of vitamin C in serum is a good prognostic parameter for disease evaluation.

30/10/06 During exacerbation, vitamin C is markedly decreased in inflammatory diseases, such as acute pneumonia and COPD, according to a new study. Serbian researchers compared the values of serum ascorbate concentration and laboratory inflammation indicators in 60 nonsmoking patients. The patients were split into three groups: 20 patients with acute pneumonia (group I), 20 patients with stable COPD (group II), and 20 patients with exacerbated COPD (group III). Researchers concluded that patients in groups I and III had significantly decreased levels of vitamin C and increased inflammation before therapy, compared with patients after therapy. It is suggested that the elevation of vitamin C in serum is a good prognostic parameter for disease evaluation.arrow

All content and features on this website are copyrighted with all rights reserved. The full details can be found in our privacy statement
Save in your AIChatGPTGoogle AIClaudePerplexityGrok
Subscribe to our newsletters
PlatformsFood Ingredients FirstNutrition InsightPackaging InsightsPersonal Care InsightsThe World of Food Ingredients
About usContact usAdvertisingSitemapArchiveEditorial team
Follow us
© CNS Media B.V 2026. All rights reserved.
Registered Office: Velperweg 18, 6824 BH Arnhem, The Netherlands
Publisher site|Privacy statement|AI & transparency
Image